These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33978159)

  • 1. SATB2 Is Expressed in a Subset of Pulmonary and Thymic Neuroendocrine Tumors.
    Vrana JA; Boland JM; Terra SBSP; Xie H; Jenkins SM; Mansfield AS; Molina JR; Cassivi SD; Roden AC
    Am J Clin Pathol; 2021 Oct; 156(5):853-865. PubMed ID: 33978159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.
    Weissferdt A; Tang X; Wistuba II; Moran CA
    Mod Pathol; 2013 Dec; 26(12):1554-60. PubMed ID: 23787439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.
    Hoskoppal D; Epstein JI; Gown AM; Arnold Egloff SA; Gordetsky JB; Shi CJ; Giannico GA
    Histopathology; 2020 Mar; 76(4):550-559. PubMed ID: 31595536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
    Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
    J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
    Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
    Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix.
    Inzani F; Angelico G; Santoro A; Travaglino A; Insabato L; Raffone A; Arciuolo D; Scaglione G; D'Alessandris N; Valente M; Carlino A; Rindi G; Zannoni GF
    Virchows Arch; 2022 Apr; 480(4):873-877. PubMed ID: 35091815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?
    Volante M; Mete O; Pelosi G; Roden AC; Speel EJM; Uccella S
    Endocr Pathol; 2021 Mar; 32(1):154-168. PubMed ID: 33641055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall.
    Inoue H; Matsushima J; Kobayashi S; Sairenchi T; Hirata H; Chida M; Ota S; Ban S; Matsumura Y
    Int J Surg Pathol; 2022 Apr; 30(2):151-159. PubMed ID: 34913369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.
    Li Z; Yuan J; Wei L; Zhou L; Mei K; Yue J; Gao H; Zhang M; Jia L; Kang Q; Huang X; Cao D
    Int J Clin Exp Pathol; 2015; 8(6):7072-82. PubMed ID: 26261600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
    Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
    J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SATB2 is expressed in Merkel cell carcinoma.
    Fukuhara M; Agnarsdóttir M; Edqvist PH; Coter A; Ponten F
    Arch Dermatol Res; 2016 Aug; 308(6):449-54. PubMed ID: 27262585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
    Hou T; Gan Q; Joseph CT; Sun X; Gong Y
    Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors.
    Valdivia D; Cheufou D; Fels B; Puhlvers S; Mardanzai K; Zaatar M; Weinreich G; Taube C; Theegarten D; Stuschke M; Schuler M; Stamatis G; Hegedus B; Aigner C
    Pathol Oncol Res; 2021; 27():629993. PubMed ID: 34257595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
    Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
    Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung.
    Del Gobbo A; Vaira V; Guerini Rocco E; Palleschi A; Bulfamante G; Ricca D; Fiori S; Bosari S; Ferrero S
    J Thorac Oncol; 2014 Nov; 9(11):1656-61. PubMed ID: 25144243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors.
    Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
    Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
    Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
    Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.